Subgroup analysis according to location in patients with stage III-IV disease revealed a trend, however non-significant, towards an improved CSS and OS for SATB2 high tumours in colon cancer, which was not evident in rectal cancer (data not shown). The gene discussed is SATB2; the disease is neoplasm.